Nu Skin Enterprises (NYSE:NUS – Get Free Report) updated its fourth quarter 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.190-0.290 for the period, compared to the consensus estimate of 0.200. The company issued revenue guidance of $410.0 million-$445.0 million, compared to the consensus revenue estimate of $441.0 million. Nu Skin Enterprises also updated its FY 2024 guidance to 0.650-0.750 EPS.
Nu Skin Enterprises Stock Performance
Shares of NUS stock traded up $0.10 during midday trading on Friday, hitting $6.55. 991,684 shares of the company were exchanged, compared to its average volume of 751,884. The firm has a market capitalization of $325.54 million, a P/E ratio of -2.20 and a beta of 1.14. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.12. Nu Skin Enterprises has a 52 week low of $5.95 and a 52 week high of $20.75. The firm’s 50 day moving average price is $6.85 and its two-hundred day moving average price is $9.87.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.04. Nu Skin Enterprises had a positive return on equity of 7.80% and a negative net margin of 8.05%. The business had revenue of $439.10 million during the quarter, compared to analysts’ expectations of $431.87 million. During the same period last year, the firm posted $0.54 EPS. The firm’s revenue for the quarter was down 12.2% compared to the same quarter last year. As a group, equities research analysts anticipate that Nu Skin Enterprises will post 0.78 earnings per share for the current year.
Nu Skin Enterprises Announces Dividend
Wall Street Analysts Forecast Growth
A number of brokerages have commented on NUS. Citigroup decreased their price objective on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a report on Tuesday, October 22nd. StockNews.com lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Wednesday, October 23rd. Finally, DA Davidson decreased their price objective on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a report on Monday, August 12th.
Read Our Latest Analysis on NUS
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Recommended Stories
- Five stocks we like better than Nu Skin Enterprises
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- California Resources Stock Could Be a Huge Long-Term Winner
- Roth IRA Calculator: Calculate Your Potential Returns
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.